Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Depression commonly complicates treatment with the cytokine interferon alfa-2b. Laboratory animals pretreated with antidepressants have less severe depression-like symptoms after the administration of a cytokine. We sought to determine whether a similar strategy would be effective in humans. METHODS: In a double-blind study of 40 patients with malignant melanoma who were eligible for high-dose interferon alfa therapy, we randomly assigned 20 patients to receive the antidepressant paroxetine and 20 to receive placebo. The treatment was begun 2 weeks before the initiation of interferon alfa and continued for the first 12 weeks of interferon alfa therapy. RESULTS: During the first 12 weeks of interferon alfa therapy, symptoms consistent with a diagnosis of major depression developed in 2 of 18 patients in the paroxetine group (11 percent) and 9 of 20 patients in the placebo group (45 percent) (relative risk, 0.24; 95 percent confidence interval, 0.08 to 0.93). Severe depression necessitated the discontinuation of interferon alfa before 12 weeks in 1 of the 20 patients in the paroxetine group (5 percent), as compared with 7 patients in the placebo group (35 percent) (relative risk, 0.14; 95 percent confidence interval, 0.05 to 0.85). The incidence of adverse events was similar in the two groups. CONCLUSIONS: In patients with malignant melanoma, pretreatment with paroxetine appears to be an effective strategy for minimizing depression induced by interferon alfa.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cytokines can directly elicit depressive symptoms and that symptoms elicited in this way can be alleviated with antidepressant medications”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Musselman et al., 2001
In the citing paper
“the effects of endotoxin-induced increases in depressive symptoms can be blunted or abated with antidepressant medications”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Musselman et al., 2001
In the citing paper
“in a study examining symptom criteria for major depression, 45% of patients receiving high dose IFN-α for cancer treatment met criteria for major depression and a third of patients dropped out of IFN-α treatment due to behavioral toxicity.98”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [98]
In the citing paper
“Strikingly, the development of this group of symptoms could be prevented by prophylactic antidepressant administration (Musselman et al., 2001).”
From The interplay between stress, inflammation, and emotional attention: relevance for depression (2019) · cites this paper as Musselman et al., 2001
In the citing paper
“IFN-α treatment causes symptoms sufficient for a major depression diagnosis in up to 50% of patients (Musselman et al., 2001).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Musselman et al., 2001
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Modelling Survival Data in Medical Research
Collett, D. (1994) · Springer eBooks · doi:10.1007/978-1-4899-3115-3 · Cited by 1,065
Maier, W., Buller, R., Philipp, M., & Heuser, I. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90072-9 · Cited by 1,044
Modelling Survival Data in Medical Research.
McLachlan, G. J., & Collett, D. (1994) · Biometrics · doi:10.2307/2533471 · Cited by 1,021
Sickness behavior as a new target for drug development
Kent, S., Bluthé, R.-M., Kelley, K. W., & Dantzer, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90012-u · Cited by 863
Antidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation
HOLSBOER, F., & BARDEN, N. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-187 · Cited by 852
Endotoxin produces a depressive-like episode in rats
Yirmiya, R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01415-2 · Cited by 604
Research works printed but not linked: 7
- Borden EC, 1998, Semin Oncol, 25, 3
- Valentine AD, 1998, Semin Oncol, 25, 39
- Yamano M, 2000, J Pharmacol Exp Ther, 292, 181
- Winer BJ. Statistical principles in experiment design. 2nd ed. New York: McGraw-Hill, 1971.
- Levenson JL, 1993, Am J Gastroenterol, 88, 760
- Taylor JL, 1998, Semin Oncol, 25, 23
- Licinio J, 1998, Semin Oncol, 25, 30
Cited by
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
“Nevertheless, in contradistinction to the prominence of depression following administration of innate immune cytokines such as interferon (IFN)-alpha to humans (12,13), administration of the T cell cytokine, IL-2, is not uncommonly associated with profound changes in mental status including psychosis, delirium, and ag…”
InfluentialSelf-citationCytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
“Consistent with their ability to ameliorate cytokine-induced depression [61], antidepressants have been shown in animals and humans to inhibit the production and/or release of proinflammatory cytokines and to stimulate the production of anti-inflammatory cytokines (such as IL-10) [81].”
BackgroundSelf-citationSlavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.-F., Rougeot, C., Pichelin, M., Cazaubiel, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114510004319 · Cited by 1,324
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Metadata
- Authors
- Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H.
- Affiliations
- Emory University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-03-29
- Volume
- 344
- Issue
- 13
- Pages
- 961-966
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338816059
- Cited by
- 1,120
- References
- 33
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 20 · 2023: 14 · 2022: 22 · 2021: 45 · 2020: 28 · 2019: 23 · 2018: 28 · 2017: 32 · 2016: 42 · 2015: 49 · 2014: 47 · 2013: 65 · 2012: 63
- FWCI
- 40.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Emory University
- Winship Cancer Institute
- National Institute of Mental Health (MH-00680, MH 60723, R01MH060723)
- National Center for Research Resources (MO1-RR30039)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- paroxetine, interferon alfa-2b, depression prevention, melanoma, high-dose interferon therapy, adverse events
- MeSH terms
- Interferon alpha-2, Adult, Aged, Antineoplastic Agents, Depressive Disorder, Double-Blind Method, Female, Humans, Male, Melanoma, Middle Aged, Recombinant Proteins, Interferon-alpha, Selective Serotonin Reuptake Inhibitors, Paroxetine, Disease-Free Survival, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Paroxetine for the prevention of depression induced by high-dose interferon alfa. https://app.cochat.ai/papers/10.1056/nejm200103293441303
- The paper
- Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. New England Journal of Medicine. https://doi.org/10.1056/nejm200103293441303
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.